Caresyntax Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
127
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$310M
- Investors
-
40
Caresyntax General Information
Description
Developer of a data-driven surgical analysis platform designed to improve patient outcomes. The company's platform utilizes artificial intelligence to analyze large volumes of video, audio, images, and clinical and operational data in and around the operating room, enabling healthcare businesses to gain information that can be used live during surgery, for post-surgical improvement, and risk assessment.
Contact Information
Website
www.caresyntax.comCorporate Office
- 900 Larkspur Landing
- Suite 120
- Larkspur, CA 94939
- United States
Corporate Office
- 900 Larkspur Landing
- Suite 120
- Larkspur, CA 94939
- United States
Caresyntax Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 15-Aug-2024 | $310M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 01-Jan-2021 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 12-Dec-2019 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Later Stage VC (Series A) | 11-Jun-2018 | $31.9M | $31.9M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2017 | Completed | Startup |
Caresyntax Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Caresyntax Comparisons
Industry
Financing
Details
Caresyntax Competitors (5)
One of Caresyntax’s 5 competitors is Proximie, a Venture Capital-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Proximie | Venture Capital-Backed | London, United Kingdom | ||||
| Touch Surgery | Formerly VC-backed | London, United Kingdom | ||||
| Qventus | Venture Capital-Backed | San Francisco, CA | ||||
| LeanTaaS | Private Equity-Backed | Santa Clara, CA | ||||
| Avail Medsystems | Formerly VC-backed | Santa Clara, CA |
Caresyntax Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Caresyntax Patents
Caresyntax Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12555334-B2 | Three-dimensional positioning and motion-detecting system for human body and object status in mixed reality and method thereof | Active | 30-Oct-2023 | ||
| US-20250139906-A1 | Three-dimensional positioning and motion-detecting system for human body and object status in mixed reality and method thereof | Active | 30-Oct-2023 | ||
| US-20240325107-A1 | System of real-time displaying prompt in synchronous displayed surgical operation video and method thereof | Pending | 31-Mar-2023 | ||
| US-D1083964-S1 | Display screen or portion of a device with transitional graphical user interface | Active | 20-Oct-2022 | ||
| US-D1084015-S1 | Display screen or portion of a device with transitional graphical user interface | Active | 20-Oct-2022 |
Caresyntax Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Caresyntax Investors (40)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aescuvest | Venture Capital | Minority | ||
| Arkin Capital | Asset Manager | Minority | ||
| Arno Capital (Nicosia) | Corporation | Minority | ||
| BioniQ UK | Corporation | Minority | ||
| BlackRock | Asset Manager | Minority |
Caresyntax Acquisitions (1)
Caresyntax’s most recent deal was a Merger/Acquisition with Syus. The deal was made on 12-Dec-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Syus | 12-Dec-2019 | Merger/Acquisition | Decision/Risk Analysis |
Caresyntax FAQs
-
When was Caresyntax founded?
Caresyntax was founded in 2013.
-
Where is Caresyntax headquartered?
Caresyntax is headquartered in Larkspur, CA.
-
What is the size of Caresyntax?
Caresyntax has 127 total employees.
-
What industry is Caresyntax in?
Caresyntax’s primary industry is Decision/Risk Analysis.
-
Is Caresyntax a private or public company?
Caresyntax is a Private company.
-
What is Caresyntax’s current revenue?
The current revenue for Caresyntax is .
-
How much funding has Caresyntax raised over time?
Caresyntax has raised $488M.
-
Who are Caresyntax’s investors?
Aescuvest, Arkin Capital, Arno Capital (Nicosia), BioniQ UK, and BlackRock are 5 of 40 investors who have invested in Caresyntax.
-
Who are Caresyntax’s competitors?
Proximie, Touch Surgery, Qventus, LeanTaaS, and Avail Medsystems are competitors of Caresyntax.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
